المؤلفون: Mbaba M; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Golding TM; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Omondi RO; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Mohunlal R; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Egan TJ; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa., Reader J; Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, 0028, South Africa., Birkholtz LM; Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, 0028, South Africa., Smith GS; Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, 7701, South Africa. Electronic address: gregory.smith@uct.ac.za.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116429. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials*/pharmacology , Antimalarials*/chemistry , Antimalarials*/chemical synthesis , Ferrous Compounds*/chemistry , Ferrous Compounds*/pharmacology , Plasmodium falciparum*/drug effects , Metallocenes*/chemistry , Metallocenes*/pharmacology , Amodiaquine*/pharmacology , Amodiaquine*/chemistry, Structure-Activity Relationship ; Molecular Structure ; Humans ; Parasitic Sensitivity Tests ; Dose-Response Relationship, Drug

عنوان ترانسليتريتد: Efficacité thérapeutique et sécurité de l’artésunate + amodiaquine et de l’artéméther + luméfantrine pour le traitement du paludisme simple à Plasmodium falciparum chez les enfants sur la côte sud-est pluvieuse de Madagascar.

المؤلفون: Irinantenaina J; Unité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Carn G; Unité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar - Drugs for Neglected Diseases initiative (DNDi), 1202, Geneva, Switzerland., Randriamiarinjatovo DNAL; Unité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Harimanana AN; Unité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Razanatsiorimalala S; Unité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar., Ralemary N; Direction Régionale de la Santé Publique Atsimo Atsinana, Farafangana, 309, Madagascar., Randriarison M; Service de Santé de District de Santé Publique, Mananjary, 317, Madagascar., Razafinjato C; National Malaria Control Program, Ministry of Health, Antananarivo, 101, Madagascar., Hotahiene R; Direction de Lutte contre les Maladies Transmissibles, Ministère de la santé publique, Antananarivo, 101, Madagascar., Randrianarivelojosia M; Unité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, 101, Madagascar - Faculté des Sciences, Université de Toliara, Toliara, 601, Madagascar.

المصدر: Parasite (Paris, France) [Parasite] 2023; Vol. 30, pp. 32. Date of Electronic Publication: 2023 Aug 30.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Princeps Editions Country of Publication: France NLM ID: 9437094 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-1042 (Electronic) Linking ISSN: 1252607X NLM ISO Abbreviation: Parasite Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine*/adverse effects , Malaria, Falciparum*/drug therapy, Humans ; Child ; Artesunate ; Madagascar ; Artemether, Lumefantrine Drug Combination

المؤلفون: Kinoshita K; Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Yoshimizu A; Department of Chemico-Pharmacological Sciences, School of Pharmacy, Kumamoto University, Kumamoto, Japan., Ichihara Y; Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Ushida K; Department of Chemico-Pharmacological Sciences, School of Pharmacy, Kumamoto University, Kumamoto, Japan., Kotani S; Global Center for Natural Resources Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Kurauchi Y; Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Seki T; Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Katsuki H; Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan. hkatsuki@gpo.kumamoto-u.ac.jp.

المصدر: Scientific reports [Sci Rep] 2022 Jun 30; Vol. 12 (1), pp. 11009. Date of Electronic Publication: 2022 Jun 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine* , Cerebral Hemorrhage*/drug therapy , Cerebral Hemorrhage*/metabolism , Encephalitis*/drug therapy , Encephalitis*/metabolism , Indoles*/pharmacology , Nuclear Receptor Subfamily 4, Group A, Member 2*/metabolism, Animals ; Ligands ; Mice ; Nitric Oxide Synthase Type II/antagonists & inhibitors ; Nitric Oxide Synthase Type II/metabolism

المؤلفون: Qian J; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Wang M; College of Food and Bioengineering, Xihua University, Chengdu, 610039, Sichuan, China., Wang Z; College of Biological and Sciences, China Agricultural University, Beijing, 100193, China., Feng R; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Zhang J; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Ye C; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Zhang M; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China., Wang B; College of Agriculture and Biotechnology, China Agricultural University, Beijing, 100193, China. wbaomin@263.net., Cui L; Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 3720 Spectrum Boulevard, Suite 304, Tampa, FL, 33612, USA. liwangcui@usf.edu.

المصدر: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2022 Feb; Vol. 414 (4), pp. 1631-1640. Date of Electronic Publication: 2021 Nov 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-2650 (Electronic) Linking ISSN: 16182642 NLM ISO Abbreviation: Anal Bioanal Chem Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine/*blood , Antimalarials/*blood , Enzyme-Linked Immunosorbent Assay/*methods, Amodiaquine/analysis ; Animals ; Antibodies, Immobilized/chemistry ; Antibodies, Monoclonal/chemistry ; Antimalarials/analysis ; Enzyme-Linked Immunosorbent Assay/economics ; Female ; Mice, Inbred BALB C ; Rats ; Time Factors ; Mice

المؤلفون: Willems S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany., Müller M; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany., Ohrndorf J; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany., Heering J; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596, Frankfurt, Germany., Proschak E; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany., Merk D; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany.; Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, 81377, Munich, Germany.

المصدر: ChemMedChem [ChemMedChem] 2022 Apr 20; Vol. 17 (8), pp. e202200026. Date of Electronic Publication: 2022 Feb 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine*/pharmacology , Nuclear Receptor Subfamily 4, Group A, Member 2*/chemistry, Ligands

المؤلفون: Kaewkhao K; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: karnrawee@tropmedres.ac., Tarning J; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine & Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Blessborn D; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine & Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

المصدر: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2021 Aug 01; Vol. 1179, pp. 122887. Date of Electronic Publication: 2021 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-376X (Electronic) Linking ISSN: 15700232 NLM ISO Abbreviation: J Chromatogr B Analyt Technol Biomed Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine/*analogs & derivatives , Amodiaquine/*blood , Antimalarials/*blood, Amodiaquine/isolation & purification ; Amodiaquine/pharmacokinetics ; Antimalarials/isolation & purification ; Antimalarials/pharmacokinetics ; Chromatography, Liquid ; High-Throughput Screening Assays ; Humans ; Limit of Detection ; Linear Models ; Liquid-Liquid Extraction ; Reproducibility of Results ; Tandem Mass Spectrometry

المؤلفون: Parvathaneni V; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA., Shukla SK; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA., Kulkarni NS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA., Gupta V; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: guptav@stjohns.edu.

المصدر: International journal of pharmaceutics [Int J Pharm] 2021 Oct 25; Vol. 608, pp. 121038. Date of Electronic Publication: 2021 Aug 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy , Nanoparticles*, A549 Cells ; Cell Line, Tumor ; Drug Delivery Systems ; Humans ; Transferrin

المؤلفون: Nhama A; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.; Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique., Nhamússua L; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Macete E; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.; Direção Nacional de Saúde Pública, Ministério da Saúde, Maputo, Mozambique., Bassat Q; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain.; Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu (University of Barcelona), Barcelona, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Salvador C; Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique., Enosse S; Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique., Candrinho B; Programa Nacional de Controlo da Malária, Ministério da Saúde, Maputo, Mozambique., Carvalho E; World Health Organization, WHO Country Office Maputo, Maputo, Mozambique., Nhacolo A; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Chidimatembue A; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Saifodine A; United States President's Malaria Initiative, United States Agency for International Development, Maputo, Mozambique., Zulliger R; United States President's Malaria Initiative, Centers for Disease Control and Prevention, Maputo, Mozambique., Lucchi N; Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA., Svigel SS; Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA., Moriarty LF; Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.; United States President's Malaria Initiative, Atlanta, GA, USA., Halsey ES; Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.; United States President's Malaria Initiative, Atlanta, GA, USA., Mayor A; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Aide P; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. pedro.aide@manhica.net.; Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique. pedro.aide@manhica.net.

المصدر: Malaria journal [Malar J] 2021 Oct 02; Vol. 20 (1), pp. 390. Date of Electronic Publication: 2021 Oct 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine/*therapeutic use , Antimalarials/*therapeutic use , Artemether, Lumefantrine Drug Combination/*therapeutic use , Artemisinins/*therapeutic use , Malaria, Falciparum/*drug therapy, Amodiaquine/standards ; Antimalarials/standards ; Artemether, Lumefantrine Drug Combination/standards ; Artemisinins/standards ; Child, Preschool ; Drug Combinations ; Humans ; Infant ; Mozambique ; Parasitemia/drug therapy ; Safety ; Treatment Outcome

المؤلفون: Xie Y; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Zhang W; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Guo L; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Center for Drug Innovation and Discovery, Hebei Normal University, Shijiazhuang, Hebei, People's Republic of China., Kril LM; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky., Begley KL; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky., Sviripa VM; Center for Drug Innovation and Discovery, Hebei Normal University, Shijiazhuang, Hebei, People's Republic of China.; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky., Chen X; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Center for Drug Innovation and Discovery, Hebei Normal University, Shijiazhuang, Hebei, People's Republic of China., Liu X; Center for Drug Innovation and Discovery, Hebei Normal University, Shijiazhuang, Hebei, People's Republic of China., Lee EY; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Department of Pathology & Laboratory Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky., He D; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Wang C; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Gao T; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Liu X; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, Kentucky., Evers BM; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Department of Surgery, College of Medicine, University of Kentucky, Lexington, Kentucky., Watt DS; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky. chunming.liu@uky.edu dwatt@uky.edu.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky.; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky., Liu C; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky. chunming.liu@uky.edu dwatt@uky.edu.; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Oct; Vol. 20 (10), pp. 1893-1903. Date of Electronic Publication: 2021 Aug 10.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Drug Synergism*, Amodiaquine/*analogs & derivatives , Cell Cycle Proteins/*antagonists & inhibitors , Colorectal Neoplasms/*drug therapy , Protein Serine-Threonine Kinases/*antagonists & inhibitors , Proto-Oncogene Proteins/*antagonists & inhibitors , Proto-Oncogene Proteins c-myc/*metabolism , Pteridines/*pharmacology, Amodiaquine/pharmacology ; Animals ; Apoptosis ; Cell Proliferation ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology ; Female ; Humans ; Male ; Mice ; Mice, Nude ; Proto-Oncogene Proteins c-myc/genetics ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays ; Polo-Like Kinase 1

المؤلفون: Cairns M; International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom., Ceesay SJ; Medical Research Council Unit The Gambia, London School of Hygiene & Tropical Medicine, London, United Kingdom., Sagara I; Malaria Research and Training Centre, Bamako, Mali., Zongo I; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso., Kessely H; Centre de Support en Santé Internationale, N'Djamena, Chad., Gamougam K; Centre de Support en Santé Internationale, N'Djamena, Chad., Diallo A; Universite Cheikh Anta Diop, Dakar, Senegal., Ogboi JS; Jedima International Health Consult, Lagos, Nigeria., Moroso D; Malaria Consortium, Kampala, Uganda., Van Hulle S; Catholic Relief Services, Dakar, Senegal., Eloike T; Jedima International Health Consult, Lagos, Nigeria., Snell P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom., Scott S; International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom., Merle C; Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland., Bojang K; Medical Research Council Unit The Gambia, London School of Hygiene & Tropical Medicine, London, United Kingdom., Ouedraogo JB; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso., Dicko A; Malaria Research and Training Centre, Bamako, Mali., Ndiaye JL; Universite Cheikh Anta Diop, Dakar, Senegal.; University of Thies, Thies, Senegal., Milligan P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

المصدر: PLoS medicine [PLoS Med] 2021 Sep 08; Vol. 18 (9), pp. e1003727. Date of Electronic Publication: 2021 Sep 08 (Print Publication: 2021).

نوع المنشور: Journal Article; Meta-Analysis; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

مواضيع طبية MeSH: Communicable Disease Control* , Seasons*, Amodiaquine/*therapeutic use , Antimalarials/*therapeutic use , Malaria, Falciparum/*prevention & control , Plasmodium falciparum/*drug effects , Pyrimethamine/*therapeutic use , Sulfadoxine/*therapeutic use, Africa, Western/epidemiology ; Age Factors ; Amodiaquine/adverse effects ; Antimalarials/adverse effects ; Case-Control Studies ; Child, Preschool ; Drug Combinations ; Female ; Humans ; Incidence ; Infant ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/epidemiology ; Malaria, Falciparum/parasitology ; Male ; Parasite Load ; Plasmodium falciparum/growth & development ; Program Evaluation ; Pyrimethamine/adverse effects ; Risk Assessment ; Risk Factors ; Sulfadoxine/adverse effects ; Time Factors ; Treatment Outcome